Evidence map›Paper›PMID 39377384›Full record

ReviewCurrent drug discovery technologies2025

Liquisolid Technique for Solubility Enhancement of Poorly Soluble Drug - A Brief Review.

Amaresh Prusty, Bikash Ranjan Jena, Vivek Barik, Piyali Khamkat, Bhakti Bhusan Barik

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current drug discovery technologies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amaresh PrustyDepartment of Pharmaceutics, Royal College of Pharmacy and Health Sciences, Berhampur, Odisha, 760002, India.
Bikash Ranjan JenaDepartment of Pharmaceutical Analysis, School of Pharmacy and Life Sciences, Centurion University of Technology and Management, Bhubaneswar, Odisha, 752050, India.
Vivek BarikDepartment of Pharmaceutical Technology, Brainware University, Kolkata. West Bengal, 700125, India.
Piyali KhamkatDepartment of Pharmaceutical Technology, Brainware University, Kolkata. West Bengal, 700125, India.
Bhakti Bhusan BarikDepartment of Pharmaceutical Technology, Brainware University, Kolkata. West Bengal, 700125, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most of the newly discovered drug candidates are lipophilic and poorly water-soluble, making it a significant challenge for the pharmaceutical industry to formulate suitable drug delivery systems. This review gives insight into an overview of the liquisolid technique (LST) and summarizes the progress of its various applications in drug delivery. This novel technique involves converting liquid drugs or drugs in a liquid state (such as solutions, suspensions, or emulsions) into dry, nonadherent, free-flowing, and readily compressible powder mixtures by blending or spraying a liquid dispersion onto specific powder carriers and coating materials. In Liquisolid systems, the liquid medication is absorbed into the interior framework of carriers. Once the carrier's interior is saturated with liquid medication, a liquid layer forms on the surface of the carrier particles, which is instantly adsorbed by the fine coating material. As a result, a dry, free-flowing, and compressible powder mixture is formed. Compared to other solubility enhancement techniques, s.a. micronization, inclusion complexation, microencapsulation, nanosuspension, and self-nano emulsions, LST is relatively simple to prepare and may offer a cost-effective solution to enhance the solubility of poorly water-soluble drugs enhancing its bioavailability in drug formulation and delivery.

Indexed as

Drug CompoundingDrug Delivery SystemsBiological AvailabilityChemistry, PharmaceuticalDrug CarriersEmulsionsHumansPharmaceutical PreparationsPowdersSolubilityDrug CarriersEmulsionsPharmaceutical PreparationsPowdersBCS classificationcarrier materialscoating materials.dissolution enhancementLiquisolid techniquepoorly water-soluble drug

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.